BTIG Reiterates Buy on BrainsWay, Maintains $20 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 86.3%

Neg 0% Neu 86.3% Pos 0%

BTIG analyst Sam Eiber reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $20 price target.

Comments

No comments yet. Be the first!